Seeking Alpha

Valeant Pharmaceuticals International (VRX): Q3 EPS of $1.15 beats by $0.02. Revenue of $884.1M...

Valeant Pharmaceuticals International (VRX): Q3 EPS of $1.15 beats by $0.02. Revenue of $884.1M (+47% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)